A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer

Daniel J. Renouf, Patricia A. Tang, Pierre Major, Monika K. Krzyzanowska, Bindi Dhesy-Thind, John R. Goffin, David W. Hedley, Lisa Wang, L. Doyle, Malcolm J. Moore

Investigational New Drugs · 2011 · 26 citations · 34 references

Concepts

References

34